Singapore markets close in 6 hours 3 minutes

VRTX Oct 2022 280.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
17.70+2.79 (+18.71%)
As of 10:57AM EDT. Market open.
Full screen
Previous close14.91
Open15.95
Bid13.90
Ask21.10
Strike280.00
Expiry date2022-10-21
Day's range15.95 - 18.13
Contract rangeN/A
Volume3
Open interestN/A
  • Zacks

    Vertex (VRTX), CRISPR to Seek FDA Nod for Hemoglobinopathy Therapy

    Vertex (VRTX) and partner CRISPR intend to start a rolling BLA submission with the FDA for their gene therapy in thalassemia and sickle cell disease indications by November 2022.

  • Motley Fool

    3 Biotech Stocks to Buy and Hold for the Next 10 Years

    Several biotech stocks have outperformed the struggling market this year. This list includes Vertex Pharmaceuticals (NASDAQ: VRTX), Exelixis (NASDAQ: EXEL), and Amgen (NASDAQ: AMGN). Let's consider why these three biotechs are solid buys for the next decade.

  • Motley Fool

    The 2 Best Stocks to Invest $5,000 in Right Now

    Between rumors of a recession, rising interest rates, and inflation, it's tough to find stocks that you're confident will keep growing instead of going to zero. Vertex Pharmaceuticals (NASDAQ: VRTX) is worth a $2,500 investment because it's the world's largest public business devoted to curing rare diseases, and it's proven to be quite adept at that goal so far.